Bio-Modeling Systems

Bio-Modeling Systems (BMSystems) is a French integrative systems biology company founded in 2004 that specializes in mechanisms-based medicine. The company utilizes its proprietary CADI™ (Computer Assisted Deductive Integration) Discovery platform to model complex biological systems and disease mechanisms, aiming to de-risk R&D and identify novel therapeutic and diagnostic targets. BMSystems operates as a "discovery factory," generating innovative hypotheses that lead to out-licensing deals or the creation of spin-off companies, such as Pherecydes Pharma and Theranexus. Its research spans diverse areas including CNS disorders, infectious diseases, oncology, and metabolic conditions. The company is privately held and 100% owned by its founders, maintaining profitability through strategic collaborations and contract research.